Industry: Medical Devices & Consumables
Published Date: 2025-11-29
Pages: 178 Pages
Report ld: 5344513
Request Sample
Customized Report
Blood Card Centrifuges Market Size(US$)

CAGR 2025-2031
3.1%
Market Size,2031
USD 259
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Blood Card Centrifuges market is projected to grow from US$ 209 million in 2024 to US$ 259 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
In 2024, global sales of Blood Card Centrifuges reached approximately 355000 units, with an average market price of about USD 588 per unit, an annual production capacity of roughly 420000 units, and an industry-average gross margin of approximately 25%.
A Blood-Card Centrifuge (also called a gel-card centrifuge or blood-type card centrifuge) is a laboratory instrument designed to perform controlled, repeatable centrifugation of gel or blood typing cards used in immunohematology. Typical units have specialty rotors that hold configurations such as 4×12, 1×12 or 24 card positions; they run at relatively low speeds with defined RCF to move plasma and red cells through gel columns or microcolumns for blood-group interpretation, antibody screening and cross-matching. Key design requirements are speed/RCF stability, low vibration/noise, spill protection and repeatability; higher-end models may include refrigeration, programmable runs, lid-lock safety and LIS connectivity. Primary users are hospital blood banks, clinical labs, blood centers and third-party testing labs.
Upstream components include motors (often BLDC), precision-machined rotors, control electronics (microcontroller/PLC boards), bearings/seals, housings/panels and the gel-cards themselves (supplied by diagnostics/consumable vendors). Many manufacturers source mechanical and electronic subsystems from contract suppliers; integrated suppliers that bundle reagents/gel cards with instruments gain higher margins and customer lock-in. End users are hospital blood banks, clinical labs, blood donation centers and third-party testing labs. Throughput per unit depends on card positions and workflow—e.g., a 12-card rotor can be run in batches multiple times per shift; labs often operate by batches based on daily sample load. Consumables are primarily gel cards, pipette tips and QC materials; gel-card consumption scales directly with sample volume. High-throughput centers typically deploy multiple units to meet demand and provide redundancy.
The global Blood Card Centrifuges market is characterized by steady, procedure-driven demand driven by hospitals, blood banks, and diagnostic laboratories that rely on gel-card and microcolumn technologies for blood typing, antibody screening, and cross-matching. Market growth is supported by the worldwide shift toward standardized immunohematology workflows, adoption of gel-card methods in emerging regions, and the ongoing replacement of older manual or non-specialized centrifuges with purpose-built units offering improved precision, safety, and automation. Competition consists of a mix of specialized laboratory-equipment manufacturers, diagnostics companies bundling instruments with consumables, and regional OEMs providing cost-efficient models. Product differentiation typically centers on reliability, programmable workflows, rotor capacity, safety features, and compatibility with specific gel-card systems. Overall, the sector remains stable, with replacement cycles, accreditation requirements, and consumable-linked workflows ensuring consistent baseline demand worldwide.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Blood Card Centrifuges market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Blood Card Centrifuges study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Blood Card Centrifuges: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Blood Card Centrifuges Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Maximum Capacity 12 cards
1.2.3 Maximum Capacity 24 cards
1.3 Market Segmentation by Application
1.3.1 Global Blood Card Centrifuges Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Blood Group Serology
1.3.3 Blood Type Test
1.3.4 Micro Column Agglutination
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Blood Card Centrifuges Revenue Estimates and Forecasts 2020-2031
2.2 Global Blood Card Centrifuges Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Blood Card Centrifuges Sales Estimates and Forecasts 2020-2031
2.4 Global Blood Card Centrifuges Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Blood Card Centrifuges Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Blood Card Centrifuges Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Maximum Capacity 12 cards Market Size by Manufacturers
3.5.2 Maximum Capacity 24 cards Market Size by Manufacturers
3.6 Global Blood Card Centrifuges Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Blood Card Centrifuges Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Blood Card Centrifuges Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Blood Card Centrifuges Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Blood Card Centrifuges Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Blood Card Centrifuges Sales and Revenue by Type (2020-2031)
6.4 North America Blood Card Centrifuges Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Blood Card Centrifuges Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Blood Card Centrifuges Sales and Revenue by Type (2020-2031)
7.4 Europe Blood Card Centrifuges Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Blood Card Centrifuges Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Blood Card Centrifuges Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Blood Card Centrifuges Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Blood Card Centrifuges Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Blood Card Centrifuges Sales and Revenue by Type (2020-2031)
9.4 Central and South America Blood Card Centrifuges Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Blood Card Centrifuges Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Blood Card Centrifuges Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Blood Card Centrifuges Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Blood Card Centrifuges Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Grifols
11.1.1 Grifols Corporation Information
11.1.2 Grifols Business Overview
11.1.3 Grifols Blood Card Centrifuges Product Models, Descriptions and Specifications
11.1.4 Grifols Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Grifols Blood Card Centrifuges Sales by Product in 2024
11.1.6 Grifols Blood Card Centrifuges Sales by Application in 2024
11.1.7 Grifols Blood Card Centrifuges Sales by Geographic Area in 2024
11.1.8 Grifols Blood Card Centrifuges SWOT Analysis
11.1.9 Grifols Recent Developments
11.2 Paramedical
11.2.1 Paramedical Corporation Information
11.2.2 Paramedical Business Overview
11.2.3 Paramedical Blood Card Centrifuges Product Models, Descriptions and Specifications
11.2.4 Paramedical Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Paramedical Blood Card Centrifuges Sales by Product in 2024
11.2.6 Paramedical Blood Card Centrifuges Sales by Application in 2024
11.2.7 Paramedical Blood Card Centrifuges Sales by Geographic Area in 2024
11.2.8 Paramedical Blood Card Centrifuges SWOT Analysis
11.2.9 Paramedical Recent Developments
11.3 BIOBASE
11.3.1 BIOBASE Corporation Information
11.3.2 BIOBASE Business Overview
11.3.3 BIOBASE Blood Card Centrifuges Product Models, Descriptions and Specifications
11.3.4 BIOBASE Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 BIOBASE Blood Card Centrifuges Sales by Product in 2024
11.3.6 BIOBASE Blood Card Centrifuges Sales by Application in 2024
11.3.7 BIOBASE Blood Card Centrifuges Sales by Geographic Area in 2024
11.3.8 BIOBASE Blood Card Centrifuges SWOT Analysis
11.3.9 BIOBASE Recent Developments
11.4 Labozon Scientific
11.4.1 Labozon Scientific Corporation Information
11.4.2 Labozon Scientific Business Overview
11.4.3 Labozon Scientific Blood Card Centrifuges Product Models, Descriptions and Specifications
11.4.4 Labozon Scientific Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Labozon Scientific Blood Card Centrifuges Sales by Product in 2024
11.4.6 Labozon Scientific Blood Card Centrifuges Sales by Application in 2024
11.4.7 Labozon Scientific Blood Card Centrifuges Sales by Geographic Area in 2024
11.4.8 Labozon Scientific Blood Card Centrifuges SWOT Analysis
11.4.9 Labozon Scientific Recent Developments
11.5 Turklab
11.5.1 Turklab Corporation Information
11.5.2 Turklab Business Overview
11.5.3 Turklab Blood Card Centrifuges Product Models, Descriptions and Specifications
11.5.4 Turklab Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Turklab Blood Card Centrifuges Sales by Product in 2024
11.5.6 Turklab Blood Card Centrifuges Sales by Application in 2024
11.5.7 Turklab Blood Card Centrifuges Sales by Geographic Area in 2024
11.5.8 Turklab Blood Card Centrifuges SWOT Analysis
11.5.9 Turklab Recent Developments
11.6 Labstac
11.6.1 Labstac Corporation Information
11.6.2 Labstac Business Overview
11.6.3 Labstac Blood Card Centrifuges Product Models, Descriptions and Specifications
11.6.4 Labstac Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Labstac Recent Developments
11.7 Stericox
11.7.1 Stericox Corporation Information
11.7.2 Stericox Business Overview
11.7.3 Stericox Blood Card Centrifuges Product Models, Descriptions and Specifications
11.7.4 Stericox Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Stericox Recent Developments
11.8 Labdex
11.8.1 Labdex Corporation Information
11.8.2 Labdex Business Overview
11.8.3 Labdex Blood Card Centrifuges Product Models, Descriptions and Specifications
11.8.4 Labdex Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Labdex Recent Developments
11.9 Nanbei Instrument
11.9.1 Nanbei Instrument Corporation Information
11.9.2 Nanbei Instrument Business Overview
11.9.3 Nanbei Instrument Blood Card Centrifuges Product Models, Descriptions and Specifications
11.9.4 Nanbei Instrument Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Nanbei Instrument Recent Developments
11.10 Jiangsu Libo Medicine Biotechnology
11.10.1 Jiangsu Libo Medicine Biotechnology Corporation Information
11.10.2 Jiangsu Libo Medicine Biotechnology Business Overview
11.10.3 Jiangsu Libo Medicine Biotechnology Blood Card Centrifuges Product Models, Descriptions and Specifications
11.10.4 Jiangsu Libo Medicine Biotechnology Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Jiangsu Libo Medicine Biotechnology Recent Developments
11.11 Allsheng
11.11.1 Allsheng Corporation Information
11.11.2 Allsheng Business Overview
11.11.3 Allsheng Blood Card Centrifuges Product Models, Descriptions and Specifications
11.11.4 Allsheng Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Allsheng Recent Developments
11.12 Suzhou Suda Saier Immune Biotechnology
11.12.1 Suzhou Suda Saier Immune Biotechnology Corporation Information
11.12.2 Suzhou Suda Saier Immune Biotechnology Business Overview
11.12.3 Suzhou Suda Saier Immune Biotechnology Blood Card Centrifuges Product Models, Descriptions and Specifications
11.12.4 Suzhou Suda Saier Immune Biotechnology Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Suzhou Suda Saier Immune Biotechnology Recent Developments
11.13 Dexiang Biotech
11.13.1 Dexiang Biotech Corporation Information
11.13.2 Dexiang Biotech Business Overview
11.13.3 Dexiang Biotech Blood Card Centrifuges Product Models, Descriptions and Specifications
11.13.4 Dexiang Biotech Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Dexiang Biotech Recent Developments
11.14 Hunan Xiang Yi Laboratory
11.14.1 Hunan Xiang Yi Laboratory Corporation Information
11.14.2 Hunan Xiang Yi Laboratory Business Overview
11.14.3 Hunan Xiang Yi Laboratory Blood Card Centrifuges Product Models, Descriptions and Specifications
11.14.4 Hunan Xiang Yi Laboratory Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Hunan Xiang Yi Laboratory Recent Developments
11.15 Yingtai Instrument
11.15.1 Yingtai Instrument Corporation Information
11.15.2 Yingtai Instrument Business Overview
11.15.3 Yingtai Instrument Blood Card Centrifuges Product Models, Descriptions and Specifications
11.15.4 Yingtai Instrument Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Yingtai Instrument Recent Developments
11.16 Bioevopeak
11.16.1 Bioevopeak Corporation Information
11.16.2 Bioevopeak Business Overview
11.16.3 Bioevopeak Blood Card Centrifuges Product Models, Descriptions and Specifications
11.16.4 Bioevopeak Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Bioevopeak Recent Developments
11.17 Sichuan Shuke
11.17.1 Sichuan Shuke Corporation Information
11.17.2 Sichuan Shuke Business Overview
11.17.3 Sichuan Shuke Blood Card Centrifuges Product Models, Descriptions and Specifications
11.17.4 Sichuan Shuke Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Sichuan Shuke Recent Developments
11.18 CAPTAIN LABCARE SCIENTIFICA
11.18.1 CAPTAIN LABCARE SCIENTIFICA Corporation Information
11.18.2 CAPTAIN LABCARE SCIENTIFICA Business Overview
11.18.3 CAPTAIN LABCARE SCIENTIFICA Blood Card Centrifuges Product Models, Descriptions and Specifications
11.18.4 CAPTAIN LABCARE SCIENTIFICA Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 CAPTAIN LABCARE SCIENTIFICA Recent Developments
11.19 Michael Laboratory Instrument
11.19.1 Michael Laboratory Instrument Corporation Information
11.19.2 Michael Laboratory Instrument Business Overview
11.19.3 Michael Laboratory Instrument Blood Card Centrifuges Product Models, Descriptions and Specifications
11.19.4 Michael Laboratory Instrument Blood Card Centrifuges Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Michael Laboratory Instrument Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Blood Card Centrifuges Industry Chain
12.2 Blood Card Centrifuges Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Blood Card Centrifuges Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Blood Card Centrifuges Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Blood Card Centrifuges Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Blood Card Centrifuges Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Blood Card Centrifuges market was valued at US$ 216 million in 2025 and is anticipated to reach US$ 267 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 129
USD 2900.00
(Single User License)
The global Blood Card Centrifuges market size was US$ 216 million in 2025 and is forecast to reach a readjusted size of US$ 267 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 102
USD 4250.00
(Single User License)
The global market for Blood Card Centrifuges was estimated to be worth US$ 216 million in 2025 and is projected to reach US$ 267 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 133
USD 3950.00
(Single User License)
The global market for Blood Card Centrifuges was estimated to be worth US$ 209 million in 2024 and is forecast to a readjusted size of US$ 259 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-11-29
Pages: 150
USD 3950.00
(Single User License)
The global Blood Card Centrifuges market size was US$ 209 million in 2024 and is forecast to a readjusted size of US$ 259 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-11-29
Pages: 105
USD 4250.00
(Single User License)
The global market for Blood Card Centrifuges was valued at US$ 209 million in the year 2024 and is projected to reach a revised size of US$ 259 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-11-29
Pages: 98
USD 2900.00
(Single User License)
The global market for Blood Card Centrifuges was estimated to be worth US$ 286 million in 2024 and is forecast to a readjusted size of US$ 353 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 126
USD 3950.00
(Single User License)
Blood Card Centrifuge is of microprocessor control system with soft touch control panel. It is made up of stainless steel centrifugal chamber and resistant to weak detergents and disinfectants. Equipped with brushless motor to make sure free maintenance.
Published Date: 2024-04-25
Pages: 110
USD 4900.00
(Single User License)
Blood Card Centrifuge is of microprocessor control system with soft touch control panel. It is made up of stainless steel centrifugal chamber and resistant to weak detergents and disinfectants. Equipped with brushless motor to make sure free maintenance.
Published Date: 2024-01-17
Pages: 104
USD 2900.00
(Single User License)
The global Blood Card Centrifuges market was valued at US$ 216 million in 2025 and is anticipated to reach US$ 267 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-04-17
Pages: 129
The global Blood Card Centrifuges market size was US$ 216 million in 2025 and is forecast to reach a readjusted size of US$ 267 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 102
The global market for Blood Card Centrifuges was estimated to be worth US$ 216 million in 2025 and is projected to reach US$ 267 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-03-06
Pages: 133
The global market for Blood Card Centrifuges was estimated to be worth US$ 209 million in 2024 and is forecast to a readjusted size of US$ 259 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-11-29
Pages: 150
The global Blood Card Centrifuges market size was US$ 209 million in 2024 and is forecast to a readjusted size of US$ 259 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-11-29
Pages: 105
The global market for Blood Card Centrifuges was valued at US$ 209 million in the year 2024 and is projected to reach a revised size of US$ 259 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-11-29
Pages: 98
The global market for Blood Card Centrifuges was estimated to be worth US$ 286 million in 2024 and is forecast to a readjusted size of US$ 353 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 126
Blood Card Centrifuge is of microprocessor control system with soft touch control panel. It is made up of stainless steel centrifugal chamber and resistant to weak detergents and disinfectants. Equipped with brushless motor to make sure free maintenance.
Published: 2024-04-25
Pages: 110
Blood Card Centrifuge is of microprocessor control system with soft touch control panel. It is made up of stainless steel centrifugal chamber and resistant to weak detergents and disinfectants. Equipped with brushless motor to make sure free maintenance.
Published: 2024-01-17
Pages: 104
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now